Clariant completes sale of Pharmaceutical Fine Chemicals

05-Jul-2006

After fulfilment of local transfer requirements and approval of all relevant authorities, Clariant has completed the sale of its Pharmaceutical Fine chemicals unit to TowerBrook Capital Partners, L.P. on June 30th 2006 for a transaction value of CHF 110 million.

The Pharmaceutical Fine Chemicals unit, part of the Life Science Chemicals Division, is subsequently reported as discontinued operation.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!